Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson; Stephen D. Robinson; Karamallah Al-Yousuf; Adam E. Hendry; Darren W. Sexton; Victoria Sherwood; Grant N. Wheeler

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood (Lead / Corresponding author), Grant N. Wheeler

Cellular Medicine

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

114 Downloads (Pure)

Abstract

[This corrects the article DOI: 10.18632/oncotarget.23378.].

Original language	English
Pages (from-to)	36645
Number of pages	1
Journal	Oncotarget
Volume	9
Issue number	93
Publication status	Published - 27 Nov 2018

Access to Document

Final Published VersionFinal published version, 683 KBLicence: CC BY

http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=26415Licence: CC BY

1 Citations
1 Article

The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Hanson, K., Robinson, S. D., Al-Yousuf, K., Hendry, A. E., Sexton, D. W., Sherwood, V. & Wheeler, G. N., 17 Dec 2017, In: Oncotarget. 9, 3, p. 3815-3829 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
15 Citations (Scopus)

155 Downloads (Pure)

Cite this

@article{26f10f4045f849129b6f43affa9717c4,

title = "Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth",

abstract = "[This corrects the article DOI: 10.18632/oncotarget.23378.].",

author = "Kimberley Hanson and Robinson, {Stephen D.} and Karamallah Al-Yousuf and Hendry, {Adam E.} and Sexton, {Darren W.} and Victoria Sherwood and Wheeler, {Grant N.}",

year = "2018",

month = nov,

day = "27",

language = "English",

volume = "9",

pages = "36645",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "93",

}

TY - JOUR

T1 - Correction

T2 - The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

AU - Hanson, Kimberley

AU - Robinson, Stephen D.

AU - Al-Yousuf, Karamallah

AU - Hendry, Adam E.

AU - Sexton, Darren W.

AU - Sherwood, Victoria

AU - Wheeler, Grant N.

PY - 2018/11/27

Y1 - 2018/11/27

N2 - [This corrects the article DOI: 10.18632/oncotarget.23378.].

AB - [This corrects the article DOI: 10.18632/oncotarget.23378.].

M3 - Article

C2 - 30564304

SN - 1949-2553

VL - 9

SP - 36645

JO - Oncotarget

JF - Oncotarget

IS - 93

ER -

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Abstract

Access to Document

Fingerprint

Research output

The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Cite this